We are live on ! Find out more
CABA icon

Cabaletta Bio

97 hedge funds and large institutions have $623M invested in Cabaletta Bio in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

370% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 10

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

94% more call options, than puts

Call options by funds: $1.44M | Put options by funds: $741K

32% more capital invested

Capital invested by funds: $470M → $623M (+$152M)

15% more funds holding

Funds holding: 8497 (+13)

10.93% more ownership

Funds ownership: 91.81%102.75% (+11%)

Holders
97
Holders Change
+13
Holders Change %
+15.48%
% of All Funds
1.54%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
26
Increased
47
Reduced
10
Closed
12
Calls
$1.44M
Puts
$741K
Net Calls
+$696K
Net Calls Change
-$208K
Name Holding Trade Value Shares
Change
Change in
Stake
RCMU
26
Rokos Capital Management (UK)
United Kingdom
$2.67M
AllianceBernstein
27
AllianceBernstein
Tennessee
$2.52M +$2.11M +154,303 +1,390%
VCIM
28
Velan Capital Investment Management
Georgia
$2.28M -$1.37M -100,000 -40%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.21M +$276K +20,171 +16%
Bank of America
30
Bank of America
North Carolina
$2.15M +$1.58M +115,688 +454%
N
31
Nuveen
North Carolina
$2.07M +$737K +53,910 +66%
WP
32
Woodline Partners
California
$2.04M +$1.83M +134,184 New
Rafferty Asset Management
33
Rafferty Asset Management
New York
$1.8M +$1.61M +118,150 New
First Manhattan
34
First Manhattan
New York
$1.79M
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$1.59M -$151K -11,042 -10%
Charles Schwab
36
Charles Schwab
California
$1.46M +$375K +27,456 +40%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$1.2M -$766K -56,052 -42%
Envestnet Asset Management
38
Envestnet Asset Management
Illinois
$1.15M +$682K +49,904 +196%
Victory Capital Management
39
Victory Capital Management
Texas
$1.01M +$95.4K +6,980 +12%
Barclays
40
Barclays
United Kingdom
$983K +$813K +59,490 +1,167%
Swiss National Bank
41
Swiss National Bank
Switzerland
$930K +$835K +61,100 New
PI
42
Putnam Investments
Massachusetts
$897K +$805K +58,934 New
CM
43
Churchill Management
California
$868K +$780K +57,047 New
EI
44
EAM Investors
California
$839K +$754K +55,156 New
BCM
45
Bridgeway Capital Management
Texas
$770K
Citigroup
46
Citigroup
New York
$756K +$575K +42,078 +552%
UOC
47
UBS O'Connor
Illinois
$736K -$451K -33,000 -41%
Osaic Holdings
48
Osaic Holdings
Arizona
$721K +$589K +43,127 +1,016%
NFGH
49
Nan Fung Group Holdings
Hong Kong
$718K +$82.4K +6,027 +15%
Two Sigma Investments
50
Two Sigma Investments
New York
$711K +$10K +734 +2%

CABA Hedge Fund Activity: Q3 2023 in Review

97 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q3 2023, worth a combined $623M — up 32% from $470M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CABA positions and 12 closed out — a net gain of 14 holders — while 47 added to existing stakes and 10 trimmed.

The largest buyer was Holocene Advisors, opening a new position worth an estimated $16.2M. The largest seller was Boxer Capital, exiting entirely with an estimated $6.97M sold.

  • 97 institutional investors held Cabaletta Bio (CABA) as of Q3 2023, up from 84 in Q2 2023.
  • Funds reported $623M of Cabaletta Bio stock for Q3 2023, up 32% quarter-over-quarter.
  • 26 funds opened new Cabaletta Bio positions in Q3 2023 and 12 closed out, a net change of +14 holders.
  • The largest Cabaletta Bio buyer in Q3 2023 was Holocene Advisors, an estimated $16.2M added.
  • The largest Cabaletta Bio seller in Q3 2023 was Boxer Capital, an estimated $6.97M sold.

Based on aggregated 13F filings for Q3 2023.